Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Wacem1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Wacem1/Cya

Common Name
Wac-KO
Product ID
S-KO-05862
Backgroud
C57BL/6JCya
Strain ID
KOCMP-225131-Wac-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Wac-KO Mouse (Catalog S-KO-05862) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Wac-KO
Strain ID
KOCMP-225131-Wac-B6J-VA
Gene Name
Wac
Product ID
S-KO-05862
Gene Alias
Wwp4, 1110067P07Rik, A230035H12Rik
Background
C57BL/6JCya
Gene Full Name
WW domain containing adaptor with coiled-coil
Modification
Conventional knockout
NCBI ID
225131 (Mouse)
Phenotype
MGI:2387357
Chromosome
Chr 18 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000167020
NCBI Transcript ID
NM_153085
Target Region
Exon 4
Size of Effective Region
~1.4 kb
Overview of Gene Research
Wac, the WW domain-containing coiled-coil adaptor, is primarily associated with transcriptional regulation, autophagy, and mitotic entry [2,3]. It is involved in pathways such as the activation of Polo-like kinase 1 (Plk1) for timely mitotic entry, and in processes like mitophagy-mediated mesenchymal stem cell (MSC) osteogenesis [2,3]. Wac's functions are of great biological importance as it impacts various physiological and pathological processes. Genetic models can be valuable for studying its role.

In osteoporosis, the levels of Wac are diminished in both patients and mouse models. Knockdown of Wac compromises Plk1 activity and delays mitotic entry, while exogenous expression of wild-type Wac can rescue these defects [2,3]. In renal allograft ischemia-reperfusion injury, inhibiting sEV-mediated lncRNA WAC-AS1 (antisense RNA of Wac) secretion can protect against the injury, suggesting a role of the Wac-related lncRNA in this disease condition [1].

In conclusion, Wac plays a crucial role in processes like mitotic entry and MSC osteogenesis. Its dysregulation is associated with diseases such as osteoporosis and renal allograft ischemia-reperfusion injury. The study of Wac using gene-knockout or conditional-knockout mouse models helps to clarify its role in these specific disease areas, providing potential therapeutic targets for treatment.

References:
1. Li, Xinyuan, Peng, Xiang, Zhou, Xiang, He, Weiyang, Gou, Xin. 2023. Small extracellular vesicles delivering lncRNA WAC-AS1 aggravate renal allograft ischemia‒reperfusion injury by inducing ferroptosis propagation. In Cell death and differentiation, 30, 2167-2186. doi:10.1038/s41418-023-01198-x. https://pubmed.ncbi.nlm.nih.gov/37532764/
2. Fan, Shuai, Li, Jinteng, Zheng, Guan, Shen, Huiyong, Ye, Guiwen. 2024. WAC Facilitates Mitophagy-mediated MSC Osteogenesis and New Bone Formation via Protecting PINK1 from Ubiquitination-Dependent Degradation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 12, e2404107. doi:10.1002/advs.202404107. https://pubmed.ncbi.nlm.nih.gov/39555688/
3. Qi, Feifei, Chen, Qinfu, Chen, Hongxia, Huang, Jun, Wang, Fangwei. . WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry. In Cell reports, 24, 546-556. doi:10.1016/j.celrep.2018.06.087. https://pubmed.ncbi.nlm.nih.gov/30021153/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research